Fredrik Öberg
Chief Tech/Sci/R&D Officer at MEDIVIR AB
Net worth: 144 726 $ as of 30/04/2024
Network origin in Fredrik Öberg first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
50
| Public Company | Pharmaceuticals: Major | 50 |
DNB Asset Management AS (Sweden)
 DNB Asset Management AS (Sweden) Investment ManagersFinance DNB Asset Management AS (Sweden) (DNBAM) is the wholly-owned Swedish subsidiary of E. Ohman J :or Fonder AB, ultimately held by the Dinkelspiel family's E. Ohman J :or AB is Sweden. The group was established in 1990 when Bergen Bank and Den norske Creditbank merged. Also known as Carlson Investment Management, DNBAM was established in 1990 and is located in Stockholm. Research and portfolio management is shared internationally within the asset management division of the DNB group, which comprises fellow subsidiaries in Oslo, New York, Hong Kong and London. DNBAM manages mutual funds, hedge funds and discretionary portfolios for corporate and institutional clients in Norway and Sweden including pension funds. Their clientele also includes family offices and high-net worth individuals. The firm is committed to ethical investment and avoids investing in companies involved in the production, stockpiling and sales of anti-personnel mines or cluster weapons.
27
| Extinct | Investment Managers | 27 |
Skandinaviska Enskilda Banken AB (Private Banking)
 Skandinaviska Enskilda Banken AB (Private Banking) Investment ManagersFinance Skandinaviska Enskilda Banken AB (Private Banking) (SEB-PB) is the private banking division of Skandinaviska Enskilda Banken AB (ST: SEB) in Sweden. Created in 2007 when SEB Asset Management merged with their private banking business, the firm provides asset management and private banking services to institutions, high-net worth individuals and retail clients from the Nordic countries, the Baltics, Germany, Luxembourg and Poland. Located in Stockholm, the firm has additional offices in the Nordic countries, the Baltics, England, Germany, Luxembourg, Poland, Singapore and Switzerland and has representative offices in France and Spain. SEB-PB offers a full spectrum of wealth management expertise and services, including equity, fixed-income, alternative products, as well as packaging and sales of mutual funds and institutional portfolios.
12
| Operating Division | Investment Managers | 12 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Fredrik Öberg via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of Uppsala | College/University | Doctorate Degree Undergraduate Degree Corporate Officer/Principal Graduate Degree Graduate Degree Graduate Degree Doctorate Degree Graduate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree Corporate Officer/Principal | |
| University of Stockholm | College/University | Corporate Officer/Principal Masters Business Admin Masters Business Admin Undergraduate Degree Graduate Degree Undergraduate Degree Graduate Degree Doctorate Degree Undergraduate Degree Corporate Officer/Principal Graduate Degree Graduate Degree | |
E. Öhman J :or Fonder AB
 E. Öhman J :or Fonder AB Investment ManagersFinance E. Öhman J:or Fonder AB (Öhman Fonder) is the wholly-owned fund management subsidiary of E. Öhman J:or Asset Management AB, itself a subsidiary of the Dinkelspeil family's E. Öhman J:or AB in Sweden. Formerly known as SalusAnsvar E Öhman Fonder, the firm was founded in 1947 and became E. Öhman J:or Fonder AB in 2005. Headquartered in Stockholm, Öhman Fonder offers fund management and discretionary portfolio management to institutions, insurance companies and wealthy individuals. | Investment Managers | Portfolio Manager-Equities Head-Equity Investments Head-Equity Investments Chief Executive Officer Portfolio Manager-Equities Head-Equity Investments Trading-Equity Portfolio Manager-Equities | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Chief Executive Officer General Counsel Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal | |
| Royal Institute of Technology | College/University | Anna Yvonne Monica Malm Bernsten | Graduate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Graduate Degree |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree | |
BioPhausia AB
 BioPhausia AB Medical DistributorsDistribution Services BioPhausia AB operates as a pharmaceutical company. It markets and distributes original drugs, generic products, and the parallel-imported medicines. The company is headquartered in Stockholm, Sweden. | Medical Distributors | Director/Board Member Chief Executive Officer Director/Board Member Chairman Director of Finance/CFO | |
| Medivir Personal AB | Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member | ||
| University of Lund | College/University | Graduate Degree Graduate Degree Doctorate Degree Graduate Degree | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Corporate Officer/Principal Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Founder Chief Tech/Sci/R&D Officer | |
| SEDANA MEDICAL AB | Medical Specialties | Director/Board Member Director of Finance/CFO Chief Executive Officer | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Stockholm School of Economics | College/University | Graduate Degree Masters Business Admin Masters Business Admin | |
Nordea Bank ABP (Broker)
 Nordea Bank ABP (Broker) Investment Banks/BrokersFinance Nordea Bank ABP (Broker) (Nordea Bank-Broker) is the Sweden-based broker/dealer division of Nordea Bank ABP (HEL: NDA-FI; OTCMKTS: NRDBY) in Finland. Headquartered in Stockholm, Nordea Bank-Broker was founded in 2001 and provides trading and execution services to various types of investors. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity Analyst-Equity | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| MENDUS AB | Biotechnology | Director/Board Member Chairman Director of Finance/CFO | |
| INDEX PHARMACEUTICALS HOLDING AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
InDex Pharmaceuticals AB
 InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| Glycovisc BioTech AB | Director/Board Member Corporate Officer/Principal Director/Board Member | ||
| XSPRAY PHARMA AB | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| OxyPharma AB | Director/Board Member Director/Board Member Chairman | ||
SEB Investment Management AB
 SEB Investment Management AB Investment ManagersFinance SEB Investment Management AB (SEB IM) is an investment management firm headquartered in Stockholm, Sweden. The firm was founded in 1978 and is a wholly-owned subsidiary of Skandinaviska Enskilda Banken AB (STO: SEB-A, ADR: SKVKY). SEB-IM offers a broad range of funds and tailored portfolios for institutional investors as well as retail and private banking clients. | Investment Managers | Portfolio Manager-Equities Portfolio Manager-Equities Portfolio Manager-Equities | |
| MEDCAP AB | Medical Specialties | Chairman Chairman Director/Board Member | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Svenska Vaccinfabriken Produktion AB
 Svenska Vaccinfabriken Produktion AB BiotechnologyHealth Technology Svenska Vaccinfabriken Produktion AB develops vaccines and immunotherapies to prevent and treat life-threatening diseases. The company is based in Stockholm, Sweden. The Swedish company was founded by Matti Sällberg, Margaret Chen, Jens Bäck, Lars Frelin. Richard Bethell has been the CEO of the company since 2022. | Biotechnology | Chief Executive Officer Director/Board Member | |
| CELLAVISION AB | Medical Specialties | Director/Board Member Director/Board Member | |
| ENEA AB | Packaged Software | Director/Board Member Director of Finance/CFO | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ABLIVA AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Artimplant AB
 Artimplant AB Medical SpecialtiesHealth Technology Artimplant AB engages in research and development of biomaterials for solutions to problems in orthopedic, odontological and reconstructive surgery. It also involves in the development, production and marketing of degradable implants designed to restore active lifestyles and improve quality of life. The company was founded by Anders Cedronius in 1990 and is headquartered in Vastra Frolunda, Sweden. | Medical Specialties | Director/Board Member Chairman | |
Healthinvest Partners AB
 Healthinvest Partners AB Investment ManagersFinance Healthinvest Partners AB (Healthinvest) is an alternative investment management firm headquartered in Stockholm, Sweden. The firm was founded by Anders Hallberg and Carl Bennet in 2006. They are owned by Atle Investment Management AB, which is a subsidiary of Bure Equity AB (STO: BURE). Healthinvest manages HealthInvest Alpha Fund – which is an actively managed global healthcare fund with a value-based approach, and HealthInvest Sustainable Healthcare – a global healthcare fund where the investment philosophy is characterized by medical progress and innovation with a strong focus on sustainability. In addition, the firm manages the fund Avanza Healthcare on behalf of Avanza. | Investment Managers | Director/Board Member Director/Board Member | |
| REJLERS AB | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Ericsson AB
 Ericsson AB Information Technology ServicesTechnology Services Ericsson AB manufactures and markets telecommunications equipment and solutions for corporate, as well as individual clients. It develops, sells, and trades goods, products, and services in the field of radio technology. The company was founded in 1952 and is headquartered in Kista, Sweden. | Information Technology Services | Director/Board Member Comptroller/Controller/Auditor | |
| Björn Axén Institut AB | Director/Board Member Director/Board Member | ||
| MOBERG PHARMA AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
BioLamina AB
 BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. | Biotechnology | Director/Board Member Director/Board Member | |
Tredje AP-fonden
 Tredje AP-fonden Investment ManagersFinance Tredje AP-fonden (AP3) is the Swedish government-owned pension fund management firm which was founded in 2001 to act as a buffer by using their capital to fund future pension payments and to generate investment returns to finance the Swedish pension system. Headquartered in Stockholm, AP3 is mandated by Parliament and regulated by the Swedish National Pension Funds Act to generate maximum possible benefit for the pension system by managing their fund capital to deliver strong investment returns at low risk. | Investment Managers | Portfolio Manager-Equities Chief Investment Officer | |
| Linköping Institute of Technology | College/University | Graduate Degree Undergraduate Degree | |
Palette Life Sciences AB
 Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Medical Specialties | Director/Board Member Chairman | |
Unimedic AB
 Unimedic AB Pharmaceuticals: MajorHealth Technology Unimedic AB manufactures and sells pharmaceuticals and chemical engineering products. It offers a wide range of licensed and unlicensed medicines and extemporaneous pharmaceuticals as well as non-prescription heath care products and pharmaceutical aids. The company was founded by Nils Ivrell, Lennart Leyoberg, and Kenth-Olov Norman in 1992 and is headquartered in Matfors, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Avidicare AB
 Avidicare AB Medical DistributorsDistribution Services Avidicare AB operates as a medical device company. It specializes in the management of airborne bacteria and virus pollution at hospitals. The firm provides Opragon, a ventilation system for reduction of airborne bacterial contamination in various hospital environments primarily for infection sensitive surgery. The company offers Opragon for preparation rooms, operating theaters, and hybrid rooms; and air curtains and external air showers. Avidicare was founded in 2010 and is headquartered in Lund, Sweden. | Medical Distributors | Director/Board Member Chairman | |
| EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Director of Finance/CFO Chief Operating Officer | |
| SPECTRACURE AB | Electronic Equipment/Instruments | Chairman Chairman | |
ABG Sundal Collier AB
 ABG Sundal Collier AB Investment Banks/BrokersFinance ABG Sundal Collier AB (ABGSC) is the Swedish securities brokerage subsidiary of ABG Sundal Collier ASA, which is owned by ABG Sundal Collier Holding ASA (FRA: DAB, OSE: ASC) in Norway. Headquartered in Stockholm, ABGSC was founded in 1997 and provides securities execution services to institutional investors. | Investment Banks/Brokers | Corporate Officer/Principal Analyst-Equity |
Statistics
International
| Sweden | 48 |
| United Kingdom | 2 |
| Denmark | 2 |
| United States | 2 |
Sectoral
| Health Technology | 24 |
| Consumer Services | 8 |
| Finance | 8 |
| Commercial Services | 4 |
| Distribution Services | 3 |
Operational
| Director/Board Member | 380 |
| Chairman | 145 |
| Corporate Officer/Principal | 112 |
| Independent Dir/Board Member | 91 |
| Chief Executive Officer | 73 |
Most connected contacts
- Stock Market
- Insiders
- Fredrik Öberg
- Company connections